Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

FDA 201: Topics in Oncology Regulation

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
FDA 201: Topics in Oncology Regulation
CBER, Microbiome, and CAR-T in Solid Tumors
Ke Liu
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
FDA 201: Topics in Oncology Regulation
Non-proportional Hazards - Evolving Analytical Approaches
Rajeshwari Sridhara
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
FDA 201: Topics in Oncology Regulation
External control arms
Pallavi Mishra-Kalyani
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
FDA 201: Topics in Oncology Regulation
Minimal residual disease
Nicole J. Gormley
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
FDA 201: Topics in Oncology Regulation
Bispecific T-cell Engager (BiTE) therapies
R. Angelo de Claro
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2019 on March 30, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5